Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Netupitant N-Oxide-d6, 2070015-12-0
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Netupitant N-Oxide-d6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Netupitant N-Oxide-d6 usage and description
Netupitant N-oxide D6 is a deuterated form of Netupitant N-oxide, which is an antiemetic drug used to prevent nausea and vomiting caused by chemotherapy. Netupitant N-oxide D6 is a potent antagonist of the neurokinin-1 (NK1) receptor, which is involved in the regulation of vomiting and other physiological processes.
The chemical formula of Netupitant N-oxide D6 is C30H34D6N4O3, and its molecular weight is 508.67 g/mol. It is a white to off-white powder that is soluble in dimethyl sulfoxide (DMSO) and methanol.
Netupitant N-oxide D6 is typically administered as a single oral dose in combination with another antiemetic drug, palonosetron, to prevent acute and delayed nausea and vomiting associated with chemotherapy. It is usually given 30 minutes before chemotherapy treatment.
The safety and efficacy of Netupitant N-oxide D6 have been evaluated in several clinical trials. It has been shown to be effective in preventing chemotherapy-induced nausea and vomiting, with a favorable safety profile. Adverse effects are generally mild and include headache, constipation, and fatigue.
In conclusion, Netupitant N-oxide D6 is a valuable drug in the management of chemotherapy-induced nausea and vomiting. Its potent antiemetic effects and favorable safety profile make it a popular choice among healthcare providers.
